Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
Clinical trial NCT06130332 · RECRUITING
Trial details
- NCT number
- NCT06130332
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2027-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.